E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/23/2012 in the Prospect News PIPE Daily.

EDAP TMS negotiates $5.63 million registered direct offering of ADS

Rodman & Renshaw sells American Depositary Shares, five-year warrants

By Devika Patel

Knoxville, Tenn., March 23 - EDAP TMS SA said it plans a $5.63 million registered direct offering of American Depositary Shares.

The company will sell 2,812,500 ADS at $2.00 per ADS. The price per share reflects a 13.79% discount to the March 22 closing share price of $2.32.

Investors will also receive warrants for 1,406,250 ordinary shares, which are each exercisable at $2.75 for five years. The strike price is an 18.53% premium to the March 22 closing share price.

Rodman & Renshaw, LLC is the agent.

Settlement is expected March 28.

Based in Lyon, France, EDAP focuses on its Ablatherm product, a high-intensity focused ultrasound treatment for prostate cancer.

Issuer:EDAP TMS SA
Issue:American Depositary Shares
Amount:$5,625,000
Shares:2,812,500
Price:$2.00
Warrants:For 1,406,250 ordinary shares
Warrant expiration:Five years
Warrant strike price:$2.75
Agent:Rodman & Renshaw, LLC
Pricing date:March 23
Settlement date:March 28
Stock symbol:Nasdaq: EDAP
Stock price:$2.32 at close March 22
Market capitalization:$26.23 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.